Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Cash from Financing Activities (2011 - 2026)

Updated

Ernexa Therapeutics (ERNA) posted Cash from Financing Activities of $6,000 for Q2 2026, down 99.9% from $4.93 million a year earlier and down 99.9% from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Cash from Financing Activities (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Ernexa Therapeutics was $9.59 million, down 20.6% year-over-year; for FY2025, it was $7.21 million, up 15.2% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
  • In prior years, Ernexa Therapeutics' Cash from Financing Activities was $6.26 million in FY2024 (-62.2%), $16.56 million in FY2023 (-15.4%), $19.58 million in FY2022 (-68.2%) and $61.59 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities since Q2 2024.
  • On a year-over-year basis, Cash from Financing Activities increased in two of the last six quarters, with growth averaging 7.7%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2026, with growth of 324.1%; the weakest was Q2 2026, with a decline of 99.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - 6,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,000.00
Mar 31, 2026 9.56 Mn
Sep 30, 2025 26,000.00
Jun 30, 2025 4.93 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 3.89 Mn
Jun 30, 2024 -22,000.00
Mar 31, 2024 1.39 Mn
Dec 31, 2023 7.70 Mn
Sep 30, 2023 8.54 Mn
Jun 30, 2023 312,000.00
Dec 31, 2022 7.59 Mn
Sep 30, 2022 6,000.00
Jun 30, 2022 -13,000.00
Mar 31, 2022 11.99 Mn
Dec 31, 2021 -419,000.00
Sep 30, 2021 3.50 Mn
Jun 30, 2021 48.56 Mn
Mar 31, 2021 9.94 Mn
API Access

Ernexa Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ERNA&period=max&api_key=YOUR_API_KEY